ExceedMedical

ExceedMedical was founded on June 18, 2020, by a senior team of industry experts from both within and outside China. Located in the Binjiang High-tech Zone of Hangzhou, the company is currently focused on the development and industrialization of innovative neurointerventional medical devices, with future plans to expand research and development into broader vascular fields. ExceedMedical's core strengths lie in its R&D team, composed of top neurosurgeons from around the world and experienced engineers, an innovative approach rooted in clinical needs, and the rapid realization of cutting-edge products. In terms of R&D capabilities, ExceedMedical’s clinical team has led several recent groundbreaking stroke clinical trials, including the Compass Trial, giving them a clear understanding of clinical device requirements. The company’s engineering team utilizes a fast design and performance evaluation simulation technology platform for medical devices, significantly accelerating the product development process. The ExceedMedical team has assisted in the validation, evaluation, and optimization of mainstream global neurointerventional products, accumulating extensive experience from concept innovation to realization and gaining deep insights into the innovation process.